PL327936A1 - Novel combinations of pyrrole carboxyamides and novel class of crebral gaba receptor ligands - Google Patents
Novel combinations of pyrrole carboxyamides and novel class of crebral gaba receptor ligandsInfo
- Publication number
- PL327936A1 PL327936A1 PL97327936A PL32793697A PL327936A1 PL 327936 A1 PL327936 A1 PL 327936A1 PL 97327936 A PL97327936 A PL 97327936A PL 32793697 A PL32793697 A PL 32793697A PL 327936 A1 PL327936 A1 PL 327936A1
- Authority
- PL
- Poland
- Prior art keywords
- novel
- crebral
- carboxyamides
- pyrrole
- receptor ligands
- Prior art date
Links
- 102000005915 GABA Receptors Human genes 0.000 title 1
- 108010005551 GABA Receptors Proteins 0.000 title 1
- DDLIQEWTNHONBH-UHFFFAOYSA-N carbamic acid;1h-pyrrole Chemical class NC(O)=O.C=1C=CNC=1 DDLIQEWTNHONBH-UHFFFAOYSA-N 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/588,711 US5804686A (en) | 1996-01-19 | 1996-01-19 | fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL327936A1 true PL327936A1 (en) | 1999-01-04 |
Family
ID=24354983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL97327936A PL327936A1 (en) | 1996-01-19 | 1997-01-14 | Novel combinations of pyrrole carboxyamides and novel class of crebral gaba receptor ligands |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US5804686A (OSRAM) |
| EP (1) | EP1019372B1 (OSRAM) |
| JP (1) | JP2000503321A (OSRAM) |
| KR (1) | KR100490108B1 (OSRAM) |
| CN (1) | CN1209805A (OSRAM) |
| AP (1) | AP1015A (OSRAM) |
| AT (1) | ATE322480T1 (OSRAM) |
| AU (1) | AU1746697A (OSRAM) |
| BG (1) | BG102634A (OSRAM) |
| BR (1) | BR9707051A (OSRAM) |
| CA (1) | CA2243317C (OSRAM) |
| CZ (1) | CZ215498A3 (OSRAM) |
| DE (1) | DE69735647T2 (OSRAM) |
| ES (1) | ES2263170T3 (OSRAM) |
| HU (1) | HUP9901018A3 (OSRAM) |
| IL (1) | IL125391A (OSRAM) |
| IS (1) | IS4798A (OSRAM) |
| MX (1) | MX9805701A (OSRAM) |
| NO (1) | NO312670B1 (OSRAM) |
| NZ (1) | NZ330861A (OSRAM) |
| OA (1) | OA10811A (OSRAM) |
| PL (1) | PL327936A1 (OSRAM) |
| RU (1) | RU2167151C2 (OSRAM) |
| SK (1) | SK94398A3 (OSRAM) |
| UA (1) | UA49001C2 (OSRAM) |
| WO (1) | WO1997026243A1 (OSRAM) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5750702A (en) * | 1993-10-27 | 1998-05-12 | Neurogen Corporation | Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands |
| US6211365B1 (en) | 1996-01-19 | 2001-04-03 | Neurogen Corporation | Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
| US5804686A (en) * | 1996-01-19 | 1998-09-08 | Neurogen Corporation | fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
| EP0888300A1 (en) | 1996-03-22 | 1999-01-07 | Neurogen Corporation | Certain fused pyrrolecarboxamides as gaba brain receptor ligands |
| US5723462A (en) * | 1996-04-26 | 1998-03-03 | Neurogen Corporation | Certain fused pyrrolecarboxamides a new class of GABA brain receptor ligands |
| GT199800179A (es) * | 1997-11-13 | 2000-05-02 | Procedimiento de sintesis de pirrol amidas. | |
| SK6872000A3 (en) | 1997-11-13 | 2002-02-05 | Pfizer Prod Inc | Method of synthesis of pyrrole amides |
| US6156898A (en) * | 1998-02-26 | 2000-12-05 | Neurogen Corporation | Substituted 1,4-dihydro-4-oxonicotinic carboxamides; GABA brain receptor ligands |
| GB9812038D0 (en) | 1998-06-04 | 1998-07-29 | Merck Sharp & Dohme | Therapeutic compound |
| AU5444499A (en) * | 1998-09-01 | 2000-03-21 | Nissan Chemical Industries Ltd. | Benzoxazine derivatives |
| US20050014939A1 (en) * | 1999-08-31 | 2005-01-20 | Neurogen Corporation | Fused pyrrolecarboxamides: GABA brain receptor ligands |
| TR200200544T2 (tr) * | 1999-08-31 | 2002-06-21 | Neurogen Corporation | Bağlı pirolkarboksamitler: gaba beyin alıcı ligantları |
| AU2001264932A1 (en) * | 2000-05-26 | 2001-12-11 | Neurogen Corporation | Oxo-imidazopyrimidine-carboxamides and their use as gaba brain receptor ligands |
| BR0113697A (pt) * | 2000-09-06 | 2003-07-22 | Neurogen Corp | Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou sal, embalagem e métodos para, para alterar a atividade transdutora de sinal dos receptores de gabaa, para tratar ansiedade, depressão, um distúrbio do sono, ou demência de alzheimer, para demonstrar a presença dos receptores de gabaa em células ou amostras de tecido e para preparar um composto |
| JP2004508352A (ja) * | 2000-09-06 | 2004-03-18 | ニューロゲン コーポレイション | 置換縮合ピロールイミン及びピラゾールイミン |
| MXPA03004939A (es) * | 2000-12-04 | 2003-09-10 | Pfizer Prod Inc | Sintesis de pirrolamidas. |
| BR0307504A (pt) * | 2002-02-07 | 2004-12-07 | Neurogen Corp | Composto ou sal farmaceuticamente aceitável, composição farmacêutica, métodos tratar doenças, para potencializar um efeito terapêutico de um agente para o snc, para melhorar a memória de curto prazo em um paciente, para determinar a presença ou ausência de receptores gabaa em uma amostra, e para alterar a atividade transdutora de sinal do receptor gabaa, embalagem, e, uso de um composto ou sal |
| ATE333455T1 (de) * | 2002-05-17 | 2006-08-15 | Neurogen Corp | Substituierte, ringkondensierte imidazolderivate: gabaa-rezeptorliganden |
| EP2275096A3 (en) | 2005-08-26 | 2011-07-13 | Braincells, Inc. | Neurogenesis via modulation of the muscarinic receptors |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| AU2006304787A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
| CA2625210A1 (en) * | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| AU2007249435A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| BRPI0716604A2 (pt) | 2006-09-08 | 2013-04-09 | Braincells Inc | combinaÇÕes contendo um derivado de 4-acilaminopiridina |
| US10954231B2 (en) | 2006-10-16 | 2021-03-23 | Bionomics Limited | Anxiolytic compounds |
| CA2954376C (en) | 2006-10-16 | 2019-06-11 | Bionomics Limited | Novel anxiolytic compounds |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| CR20200540A (es) * | 2010-08-31 | 2021-03-16 | Meiji Seika Pharma Co Ltd | DERIVADOS DE AMINA PARA EL CONTROL DE PLAGAS (Divisional 2019-0244) |
| CA2828780A1 (en) | 2011-03-02 | 2012-09-07 | Bionomics Limited | Novel small-molecules as therapeutics |
| JP6055817B2 (ja) | 2011-05-12 | 2016-12-27 | バイオノミックス リミテッド | ナフチリジンの調製方法 |
| CN120081825B (zh) * | 2025-05-07 | 2025-09-16 | 天津匠新致成科技有限公司 | 一种化合物及其制备方法和医药用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3455943A (en) * | 1966-10-21 | 1969-07-15 | American Cyanamid Co | Certain 5,8-dihydro-beta-carbolines |
| US4075343A (en) * | 1976-09-13 | 1978-02-21 | Pfizer Inc. | Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof |
| DE3029980A1 (de) * | 1980-08-08 | 1982-03-11 | Boehringer Mannheim Gmbh, 6800 Mannheim | Indolderivate und verfahren zu ihrer herstellung |
| JPS57123180A (en) * | 1980-12-17 | 1982-07-31 | Schering Ag | 3-substituted beta-carboline, manufacture and psychotropic drug containing same |
| DE3147276A1 (de) * | 1981-11-28 | 1983-06-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur herstellung von indolderivaten, deren verwendung als wertvolle zwischenprodukte und neue 4-hydroxyindole |
| DE3246932A1 (de) * | 1982-12-16 | 1984-06-20 | Schering AG, 1000 Berlin und 4709 Bergkamen | Substituierte 5h-pyrimido(5,4-b)indole |
| DE3335323A1 (de) * | 1983-09-27 | 1985-04-04 | Schering AG, 1000 Berlin und 4709 Bergkamen | Substituierte ss-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| GB8429739D0 (en) * | 1984-11-24 | 1985-01-03 | Fbc Ltd | Fungicides |
| DE3535927A1 (de) * | 1985-10-04 | 1987-04-09 | Schering Ag | 3-vinyl- und 3-ethinyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel |
| CA2091986C (en) * | 1990-10-09 | 1995-11-28 | Andrew Thurkauf | Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands |
| US5243049A (en) * | 1992-01-22 | 1993-09-07 | Neurogen Corporation | Certain pyrroloquinolinones: a new class of GABA brain receptor ligands |
| WO1993017025A1 (en) * | 1992-02-19 | 1993-09-02 | The Upjohn Company | 3-substituted imidazo(1,5-a)quinoxalines and quinazolines with cns activity |
| US5266698A (en) * | 1992-04-30 | 1993-11-30 | Neurogen Corporation | Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands |
| WO1994017095A1 (en) * | 1993-01-29 | 1994-08-04 | Ariad Pharmaceuticals, Inc. | Analogs of receptor tyrosine activation motifs and therapeutic uses thereof |
| FR2705095B1 (fr) * | 1993-05-12 | 1995-06-23 | Adir | Nouveaux indoles substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| US5484944A (en) * | 1993-10-27 | 1996-01-16 | Neurogen Corporation | Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands |
| US5804686A (en) * | 1996-01-19 | 1998-09-08 | Neurogen Corporation | fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
-
1996
- 1996-01-19 US US08/588,711 patent/US5804686A/en not_active Expired - Fee Related
-
1997
- 1997-01-14 CA CA002243317A patent/CA2243317C/en not_active Expired - Fee Related
- 1997-01-14 NZ NZ330861A patent/NZ330861A/xx unknown
- 1997-01-14 DE DE69735647T patent/DE69735647T2/de not_active Expired - Fee Related
- 1997-01-14 RU RU98115534/04A patent/RU2167151C2/ru not_active IP Right Cessation
- 1997-01-14 BR BR9707051A patent/BR9707051A/pt not_active Application Discontinuation
- 1997-01-14 ES ES97904754T patent/ES2263170T3/es not_active Expired - Lifetime
- 1997-01-14 AP APAP/P/1998/001297A patent/AP1015A/en active
- 1997-01-14 AT AT97904754T patent/ATE322480T1/de not_active IP Right Cessation
- 1997-01-14 SK SK943-98A patent/SK94398A3/sk unknown
- 1997-01-14 HU HU9901018A patent/HUP9901018A3/hu unknown
- 1997-01-14 CZ CZ982154A patent/CZ215498A3/cs unknown
- 1997-01-14 JP JP9526110A patent/JP2000503321A/ja not_active Ceased
- 1997-01-14 EP EP97904754A patent/EP1019372B1/en not_active Expired - Lifetime
- 1997-01-14 WO PCT/US1997/000519 patent/WO1997026243A1/en not_active Ceased
- 1997-01-14 UA UA98073904A patent/UA49001C2/uk unknown
- 1997-01-14 PL PL97327936A patent/PL327936A1/xx unknown
- 1997-01-14 AU AU17466/97A patent/AU1746697A/en not_active Abandoned
- 1997-01-14 KR KR10-1998-0705446A patent/KR100490108B1/ko not_active Expired - Fee Related
- 1997-01-14 CN CN97191759A patent/CN1209805A/zh active Pending
- 1997-01-14 IL IL12539197A patent/IL125391A/en not_active IP Right Cessation
-
1998
- 1998-07-15 BG BG102634A patent/BG102634A/xx unknown
- 1998-07-15 MX MX9805701A patent/MX9805701A/es not_active IP Right Cessation
- 1998-07-15 OA OA9800115A patent/OA10811A/en unknown
- 1998-07-16 IS IS4798A patent/IS4798A/is unknown
- 1998-07-17 NO NO19983315A patent/NO312670B1/no not_active IP Right Cessation
- 1998-09-04 US US09/148,247 patent/US6080873A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| BG102634A (en) | 1999-08-31 |
| BR9707051A (pt) | 1999-07-20 |
| DE69735647T2 (de) | 2007-05-03 |
| CN1209805A (zh) | 1999-03-03 |
| ES2263170T3 (es) | 2006-12-01 |
| US6080873A (en) | 2000-06-27 |
| IS4798A (is) | 1998-07-16 |
| EP1019372B1 (en) | 2006-04-05 |
| IL125391A0 (en) | 1999-03-12 |
| EP1019372A1 (en) | 2000-07-19 |
| NZ330861A (en) | 2000-03-27 |
| KR100490108B1 (ko) | 2005-11-25 |
| IL125391A (en) | 2004-07-25 |
| UA49001C2 (uk) | 2002-09-16 |
| CA2243317A1 (en) | 1997-07-24 |
| RU2167151C2 (ru) | 2001-05-20 |
| MX9805701A (es) | 1998-11-30 |
| NO983315D0 (no) | 1998-07-17 |
| SK94398A3 (en) | 1999-02-11 |
| HUP9901018A2 (hu) | 1999-07-28 |
| NO983315L (no) | 1998-09-03 |
| CA2243317C (en) | 2007-09-25 |
| ATE322480T1 (de) | 2006-04-15 |
| US5804686A (en) | 1998-09-08 |
| DE69735647D1 (de) | 2006-05-18 |
| AP9801297A0 (en) | 1998-09-30 |
| OA10811A (en) | 2001-07-05 |
| CZ215498A3 (cs) | 1999-09-15 |
| HUP9901018A3 (en) | 1999-11-29 |
| JP2000503321A (ja) | 2000-03-21 |
| AU1746697A (en) | 1997-08-11 |
| AP1015A (en) | 2001-09-28 |
| WO1997026243A1 (en) | 1997-07-24 |
| NO312670B1 (no) | 2002-06-17 |
| KR19990077300A (ko) | 1999-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL327936A1 (en) | Novel combinations of pyrrole carboxyamides and novel class of crebral gaba receptor ligands | |
| IL119433A0 (en) | Determination of software functionality | |
| DE69730228D1 (de) | Multimedia-anrufzentrale | |
| PL332777A1 (en) | N-substituted 2-cyanopyrolydines | |
| GB9616105D0 (en) | TrkA binding site of NGF | |
| EP0696742A3 (en) | Component test with direct digital synthesis | |
| PL329070A1 (en) | Novel dissymetrical synthesis of r-alpha-propylpiperonylamine and its analoques | |
| IL135564A0 (en) | POLYCYCLIC α-AMINO-ɛ-CAPROLACTAMS AND RELATED COMPOUNDS | |
| IL130125A0 (en) | Preparation of N-substituted 3-hydroxypyrazoles | |
| HRP970296A2 (en) | Novel pyrrole derivatives | |
| HU9702480D0 (en) | New polymorphe modification of doxazosin-mesylate | |
| GB2300260B (en) | Determination of ligand binding affinity | |
| HU9702479D0 (en) | New polymorphe modification of doxazosin-mesylate | |
| GB9617732D0 (en) | Sustained-release preparation | |
| SG67525A1 (en) | Mixing apparatus with compatible multiplexing of internal and external voice signals | |
| GB9610691D0 (en) | Ringing tone apparatus | |
| GB2313506B (en) | Tone filter | |
| GB9723062D0 (en) | Improvements relating to antibodies and libraries thereof | |
| AP9801391A0 (en) | Method of synthesis of pyrrole amides | |
| SI1030838T1 (en) | Method of synthesis of pyrrole amides | |
| IL184196A0 (en) | Receptor activator of nf-kappa b ligand | |
| TW307276U (en) | Improved structure of plate | |
| PL313849A1 (en) | Beta-aminoesters of o-hydrobenzylamides | |
| TW314168U (en) | Structural improvement of combustion device | |
| TW452039U (en) | Improved binding ring |